These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 32674367)

  • 1. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
    Pajares M; I Rojo A; Manda G; Boscá L; Cuadrado A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32674367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
    L'Episcopo F; Tirolo C; Peruzzotti-Jametti L; Serapide MF; Testa N; Caniglia S; Balzarotti B; Pluchino S; Marchetti B
    Stem Cells; 2018 Aug; 36(8):1179-1197. PubMed ID: 29575325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular α-synuclein--a possible initiator of inflammation in Parkinson's disease.
    Ren WQ; Tian ZM; Yin F; Sun JZ; Zhang JN
    Pharmazie; 2016 Feb; 71(2):51-5. PubMed ID: 27004367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in Parkinson's disease.
    Tufekci KU; Meuwissen R; Genc S; Genc K
    Adv Protein Chem Struct Biol; 2012; 88():69-132. PubMed ID: 22814707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation and cell therapy for Parkinson's disease.
    Li F; Zhu S; Wu C; Yan C; Liu Y; Shugan L
    Front Biosci (Schol Ed); 2011 Jun; 3(4):1407-20. PubMed ID: 21622277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of microglia on the pathogenesis of Parkinson's disease.
    Long-Smith CM; Sullivan AM; Nolan YM
    Prog Neurobiol; 2009 Nov; 89(3):277-87. PubMed ID: 19686799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.
    Qian L; Flood PM; Hong JS
    J Neural Transm (Vienna); 2010 Aug; 117(8):971-9. PubMed ID: 20571837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.
    Rocha NP; de Miranda AS; Teixeira AL
    Biomed Res Int; 2015; 2015():628192. PubMed ID: 26295044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
    Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
    Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.
    de Araújo FM; Cuenca-Bermejo L; Fernández-Villalba E; Costa SL; Silva VDA; Herrero MT
    Cell Mol Neurobiol; 2022 Jul; 42(5):1283-1300. PubMed ID: 33387119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress on neural mechanism of peripheral inflammation in Parkinson's disease].
    Liu YT; Sun MH; Cai CW; Ren C; Niu HC
    Sheng Li Xue Bao; 2019 Oct; 71(5):732-740. PubMed ID: 31646327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and infection in Parkinson's disease.
    Arai H; Furuya T; Mizuno Y; Mochizuki H
    Histol Histopathol; 2006 Jun; 21(6):673-8. PubMed ID: 16528677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
    Teismann P; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):149-61. PubMed ID: 15338271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.
    Collins LM; Toulouse A; Connor TJ; Nolan YM
    Neuropharmacology; 2012 Jun; 62(7):2154-68. PubMed ID: 22361232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation as a causative factor in the aetiology of Parkinson's disease.
    Whitton PS
    Br J Pharmacol; 2007 Apr; 150(8):963-76. PubMed ID: 17339843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.